foxtel expertstalking up biotech sector, page-3

K,

I don't agree with you. Positive announcements have ALWAYS been a dime a dozen at NuSep. True disclosure has always been more difficult or non existent.

What's also been freely flowing is negative cashflow. Remember, the wages bill exceeds the total sales at NuSep and will contuinue, unless they do some smoke and mirors 'sales' to PRIME, which is no doubt what they are planning (money out of one pocket into the other but boosts the numbers for their bonuses).

No one is going to take this company seriously while the skeletons remain in the closet, no matter how many positive announcements come out. The announcement of the trial run of PRIME has shown that to be true.

We need some real positive cashflow from something other than the issuance of shares.

Predictions of double digits for the share price are nice, but we're still awaiting the eating of the pudding and the week after the trial sucess announcement has proven that there just isn't any serious buyers interested. Maybe it is because the PRIME share issuance has now become opaque due to the mismanagement of the regulatory side. Or is it that their due diligence has uncovered more serious skeletons?